These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 29999129

  • 1. [Toxic epidermal necrolysis during a hemophagocytic syndrome secondary to Hodgkin lymphoma. Report of one case].
    Peña C, Voisin J, González JT, Villegas P.
    Rev Med Chil; 2018 Apr; 146(4):523-527. PubMed ID: 29999129
    [Abstract] [Full Text] [Related]

  • 2. [Stevens-Johnson syndrome and Hodgkin's disease: A fortuitous association or paraneoplastic syndrome?].
    Schoeffler A, Levy E, Weinborn M, Cuny JF, Schmutz JL, Barbaud A, Cribier B, Bursztejn AC.
    Ann Dermatol Venereol; 2014 Feb; 141(2):134-40. PubMed ID: 24507208
    [Abstract] [Full Text] [Related]

  • 3. Rituximab, etoposide, methylprednisolone, high-dose cytarabine, and cisplatin in the treatment of secondary hemophagocytic lymphohistiocytosis with classical Hodgkin lymphoma: a case report and review of the literature.
    Hu S, Bansal P, Lynch D, Rojas Hernandez CM, Dayao Z.
    J Med Case Rep; 2016 Dec 20; 10(1):365. PubMed ID: 27998299
    [Abstract] [Full Text] [Related]

  • 4. Hodgkin's lymphoma preceded by haemophagocytic lymphohistiocytosis.
    Morita Y, Kenzaka T, Yoshimoto H, Ohno N.
    BMJ Case Rep; 2013 Jun 10; 2013():. PubMed ID: 23761512
    [Abstract] [Full Text] [Related]

  • 5. Advanced Lymphocyte-rich Classical Hodgkin Lymphoma Complicated with Fatal Hemophagocytic Syndrome.
    Ichikawa S, Takahashi T, Katsushima H, Fukuhara N, Ichinohasama R, Harigae H.
    Intern Med; 2016 Jun 10; 55(2):191-6. PubMed ID: 26781022
    [Abstract] [Full Text] [Related]

  • 6. Hemoperfusion for Hodgkin lymphoma-associated hemophagocytic lymphohistiocytosis.
    Tatara R, Sato M, Fujiwara S, Oh I, Muroi K, Ozawa K, Nagai T.
    Intern Med; 2014 Jun 10; 53(20):2365-8. PubMed ID: 25318804
    [Abstract] [Full Text] [Related]

  • 7. Hodgkin's lymphoma with HLH and complete remission with brentuximab-based therapy.
    Knox B, Singh D, Mai H, Mirza K.
    BMJ Case Rep; 2019 Dec 08; 12(12):. PubMed ID: 31818889
    [Abstract] [Full Text] [Related]

  • 8. Prognostic factors for advanced-stage human immunodeficiency virus-associated classical Hodgkin lymphoma treated with doxorubicin, bleomycin, vinblastine, and dacarbazine plus combined antiretroviral therapy: a multi-institutional retrospective study.
    Castillo JJ, Bower M, Brühlmann J, Novak U, Furrer H, Tanaka PY, Besson C, Montoto S, Cwynarski K, Abramson JS, Dalia S, Bibas M, Connors JM, Furman M, Nguyen ML, Cooley TP, Beltran BE, Collins JA, Vose JM, Xicoy B, Ribera JM, HIV-Associated Hodgkin Lymphoma in the cART Era Study Group.
    Cancer; 2015 Feb 01; 121(3):423-31. PubMed ID: 25251326
    [Abstract] [Full Text] [Related]

  • 9. Early versus late intensification for patients with high-risk Hodgkin lymphoma-3 cycles of intensive chemotherapy plus low-dose lymph node radiation therapy versus 4 cycles of combined doxorubicin, bleomycin, vinblastine, and dacarbazine plus myeloablative chemotherapy with autologous stem cell transplantation: five-year results of a randomized trial on behalf of the GOELAMS Group.
    Arakelyan N, Berthou C, Desablens B, de Guibert S, Delwail V, Moles MP, Quittet P, Jais JP, Colonna P, Andrieu JM, Groupe Ouest-Est d'Etude des Leucémies et Autres Maladies du Sang.
    Cancer; 2008 Dec 15; 113(12):3323-30. PubMed ID: 18988286
    [Abstract] [Full Text] [Related]

  • 10. Outcome of patients older than 60 years with classical Hodgkin lymphoma treated with front line ABVD chemotherapy: frequent pulmonary events suggest limiting the use of bleomycin in the elderly.
    Stamatoullas A, Brice P, Bouabdallah R, Mareschal S, Camus V, Rahal I, Franchi P, Lanic H, Tilly H.
    Br J Haematol; 2015 Jul 15; 170(2):179-84. PubMed ID: 25891777
    [Abstract] [Full Text] [Related]

  • 11. What's beneath the surface? Stevens-Johnson syndrome/toxic epidermal necrolysis combined with haemophagocytic lymphohistiocytosis: a case report.
    Nic Ionmhain UM, Knezevic BR, Barraclough A, Lucas M, Anstey M.
    Anaesth Intensive Care; 2017 Jan 15; 45(1):125-127. PubMed ID: 28072947
    [No Abstract] [Full Text] [Related]

  • 12. Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial.
    Behringer K, Goergen H, Hitz F, Zijlstra JM, Greil R, Markova J, Sasse S, Fuchs M, Topp MS, Soekler M, Mathas S, Meissner J, Wilhelm M, Koch P, Lindemann HW, Schalk E, Semrau R, Kriz J, Vieler T, Bentz M, Lange E, Mahlberg R, Hassler A, Vogelhuber M, Hahn D, Mezger J, Krause SW, Skoetz N, Böll B, von Tresckow B, Diehl V, Hallek M, Borchmann P, Stein H, Eich H, Engert A, German Hodgkin Study Group, Swiss Group for Clinical Cancer Research, Arbeitsgemeinschaft Medikamentöse Tumortherapie.
    Lancet; 2015 Apr 11; 385(9976):1418-27. PubMed ID: 25539730
    [Abstract] [Full Text] [Related]

  • 13. Consolidation radiation after complete remission in Hodgkin's disease following six cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine chemotherapy: is there a need?
    Laskar S, Gupta T, Vimal S, Muckaden MA, Saikia TK, Pai SK, Naresh KN, Dinshaw KA.
    J Clin Oncol; 2004 Jan 01; 22(1):62-8. PubMed ID: 14657226
    [Abstract] [Full Text] [Related]

  • 14. Risk-adapted therapy with three or six cycles of doxorubicin/bleomycin/vinblastine/dacarbazine plus involved-field radiation therapy in Hodgkin lymphoma, based on prognosis at diagnosis and early response: results from the GATLA study.
    Pavlovsky S, Corrado C, Pavlovsky MA, Prates MV, Zoppegno L, Giunta M, Cerutti I, Palomino E, Pagani F, Lastiri F, Bar D, Bezares RF, Avila G.
    Clin Lymphoma Myeloma Leuk; 2010 Jun 01; 10(3):181-5. PubMed ID: 20511162
    [Abstract] [Full Text] [Related]

  • 15. Lomustine, etoposide, vindesine, and dexamethasone (CEVD) in Hodgkin's lymphoma refractory to cyclophosphamide, vincristine, procarbazine, and prednisone (COPP) and doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD): a multicenter trial of the German Hodgkin Study Group.
    Pfreundschuh MG, Schoppe WD, Fuchs R, Pflüger KH, Loeffler M, Diehl V.
    Cancer Treat Rep; 1987 Dec 01; 71(12):1203-7. PubMed ID: 2446751
    [Abstract] [Full Text] [Related]

  • 16. Stevens Johnson syndrome-Toxic Epidermal Necrolysis Overlap induced by sulfasalazine treatment: a case report.
    Zizi N, Elmrahi A, Dikhaye S, Fihmi N, Alami Z.
    Tunis Med; 2015 Jul 01; 93(7):413-5. PubMed ID: 26757493
    [Abstract] [Full Text] [Related]

  • 17. [Complete remission of relapsed mixed cellularity Hodgkin's disease treated with rituximab].
    Al-Ali HK, Wittekind C, Niederwieser D.
    Dtsch Med Wochenschr; 2007 Aug 01; 132(33):1688-91. PubMed ID: 17713864
    [Abstract] [Full Text] [Related]

  • 18. Hemophagocytic Syndrome Associated with Hodgkin's Lymphoma First Presenting as Fever and Pancytopenia.
    de Mello RA, Fonseca E, Brochado M, Quinaz JM.
    Case Rep Med; 2010 Aug 01; 2010():759651. PubMed ID: 21076537
    [Abstract] [Full Text] [Related]

  • 19. 18F-FDG PET after 2 cycles of ABVD predicts event-free survival in early and advanced Hodgkin lymphoma.
    Cerci JJ, Pracchia LF, Linardi CC, Pitella FA, Delbeke D, Izaki M, Trindade E, Soares J, Buccheri V, Meneghetti JC.
    J Nucl Med; 2010 Sep 01; 51(9):1337-43. PubMed ID: 20720036
    [Abstract] [Full Text] [Related]

  • 20. ABVD versus modified stanford V versus MOPPEBVCAD with optional and limited radiotherapy in intermediate- and advanced-stage Hodgkin's lymphoma: final results of a multicenter randomized trial by the Intergruppo Italiano Linfomi.
    Gobbi PG, Levis A, Chisesi T, Broglia C, Vitolo U, Stelitano C, Pavone V, Cavanna L, Santini G, Merli F, Liberati M, Baldini L, Deliliers GL, Angelucci E, Bordonaro R, Federico M, Intergruppo Italiano Linfomi.
    J Clin Oncol; 2005 Dec 20; 23(36):9198-207. PubMed ID: 16172458
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.